Propeller’s research team recently shared new data insights into the value of connected digital technology at the virtual AAAAI Annual Meeting.
One abstract presented with leading allergists and pulmonologists at Children’s Hospital Colorado has confirmed what we’ve long suspected about our digital health platform: Patients are more adherent to their asthma medication regimen when they connect both their controller and rescue inhalers to Propeller.
In the study of 5,105 patients with asthma, patients using Propeller for controller and rescue usage monitoring had nearly 5% higher absolute medication adherence than those who used Propeller to track their controller medication alone. Improvements in adherence were highest in patients with very poor control* of their asthma — often the patients who stand to benefit the most from a platform like Propeller.
Why was this case? We can’t say for certain, but it’s possible that connecting both rescue and controller inhaler medications gives the patient (and their provider) a more holistic picture of how well a patient is managing their asthma symptoms between clinic visits.
When a rescue inhaler is connected to Propeller, the patient gains insight on their rescue use trends and what might be triggering their symptoms. This information can help the patient better understand the importance of adhering to their controller medication and encourage them to take doses on time.
This is an encouraging signal that connecting all of a patient’s inhalers to a digital health platform may be important for engagement and, ultimately, asthma outcomes.
If you have questions about how Propeller works for patients and health plan members with asthma or COPD, email us at [email protected]. If you have questions for the research team, email [email protected].
*As determined by the Asthma Control Test (ACT)™, a five-question patient survey used to measure asthma control as defined by the National Heart, Lung, and Blood Institute (NHLBI).